RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Nanosonics Limited (NNCSF – Research Report) on August 22 and set a price target of A$5.00. The company’s shares closed last Tuesday at $2.95.
According to TipRanks, Wong-Pan is a 3-star analyst with an average return of 3.7% and a 55.00% success rate. Wong-Pan covers the Healthcare sector, focusing on stocks such as Cochlear Limited, CSL, and Nanosonics Limited.
In addition to RBC Capital, Nanosonics Limited also received a Hold from Bell Potter’s John Hester in a report issued yesterday. However, on the same day, Citi maintained a Sell rating on Nanosonics Limited (Other OTC: NNCSF).
See the top stocks recommended by analysts >>
The company has a one-year high of $3.82 and a one-year low of $2.07. Currently, Nanosonics Limited has an average volume of 454.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Nanosonics Ltd is an Australia based healthcare equipment manufacturing company. It manufactures and distributes the trophon EPR ultrasound probe disinfector, which reduces the risk of ultrasound-related cross-infection. It also manufactures the associated consumables and accessories such as the trophon wall mount, trophon printer, trophon cart, trophon curved probe positioner and others. In addition, the company manufactures and commercializes infection control and decontamination products and services and related technologies. The entity operates in Australia and other countries, of which key revenue is derived from North America.
Read More on NNCSF:
